Grail (GRAL) FCF Margin (2023 - 2026)
Grail's (GRAL) quarterly FCF Margin came in at 181.62% in Q2 2026, up 3537.0% on a YoY basis from 4.99% in Q2 2025, and up 15.34% quarter-over-quarter from 214.52% in Q1 2026.
Powered by 
Analysis
Grail (GRAL) FCF Margin (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported FCF Margin for 4 consecutive years, with 181.62% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 3537.0% year-over-year to 181.62%; the trailing twelve-month figure through Jun 2026 stood at 188.39% (up 8845.0% YoY), and the FY2025 full-year result was 203.79%, up 25990.0% from the prior year.
- FCF Margin rose to 181.62% in Q2 2026 per GRAL's latest filing, from 214.52% in the prior quarter.
- Across five years, FCF Margin topped out at 151.98% in Q4 2023 and bottomed at 785.28% in Q1 2024.
- Historically, FCF Margin has averaged 358.24% across 4 years, with a median of 245.2% in 2024.
- The sharpest annual moves came in 2024 and 2025: FCF Margin plunged 9321 bps in 2024, then jumped 48600 bps in 2025.
- Over 4 years, FCF Margin stood at 151.98% in 2023, then tumbled by 61 bps to 245.2% in 2024, then climbed by 28 bps to 175.8% in 2025, then declined by 3 bps to 181.62% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 181.62%, 214.52%, and 175.8% for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -1.15% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 8.41% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -20.76% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -3.57% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 2.43% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 13.08% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 4.65% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -10.60% |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -181.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -181.62% |
| Mar 31, 2026 | -214.52% |
| Sep 30, 2025 | -175.80% |
| Jun 30, 2025 | -216.99% |
| Mar 31, 2025 | -299.27% |
| Dec 31, 2024 | -245.20% |
| Sep 30, 2024 | -368.39% |
| Jun 30, 2024 | -541.71% |
| Mar 31, 2024 | -785.28% |
| Dec 31, 2023 | -151.98% |
| Oct 1, 2023 | -759.88% |